Finance Watch: Atlas Raises $450m Venture Fund For Biotech Breakthroughs
VC Cash Continues To Flow Despite Public Market Woes
Both Atlas and Foresite Capital announced new funds focused on start-ups. Also, Flagship launched Vesalius with $75m in initial funding, Innoviva sold $225m in notes, Hookipa priced a $75m follow-on offering and job cuts were revealed by Epizyme, Flexion, Deciphera and Gemini.
